David Katz Teva Pharmaceutical Industries LTD Transaction History

Matrix Asset Advisors Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2017 May 10, 2017	SELL	N/A	-261,000 Closed	0 $0
Q4 2016 Feb 08, 2017	BUY	N/A	1,742 Added 0.67%	261,000 $9.46 Million
Q3 2016 Nov 07, 2016	BUY	N/A	23,786 Added 10.1%	259,258 $11.9 Million
Q2 2016 Aug 03, 2016	BUY	N/A	5,170 Added 2.24%	235,472 $11.8 Million
Q1 2016 May 05, 2016	BUY	N/A	3,353 Added 1.48%	230,302 $12.3 Million
Q4 2015 Feb 08, 2016	SELL	N/A	-121,350 Reduced 34.84%	226,949 $14.9 Million
Q3 2015 Nov 10, 2015	SELL	N/A	-14,559 Reduced 4.01%	348,299 $19.7 Million
Q2 2015 Aug 07, 2015	SELL	N/A	-5,245 Reduced 1.42%	362,858 $21.4 Million
Q1 2015 May 08, 2015	BUY	N/A	4,389 Added 1.21%	368,103 $22.9 Million
Q4 2014 Feb 10, 2015	BUY	N/A	252 Added 0.07%	363,714 $20.9 Million
Q3 2014 Nov 06, 2014	SELL	N/A	-1,710 Reduced 0.47%	363,462 $19.5 Million
Q2 2014 Aug 11, 2014	SELL	N/A	-5,305 Reduced 1.43%	365,172 $19.1 Million
Q1 2014 May 08, 2014	SELL	N/A	-54,984 Reduced 12.92%	370,477 $19.6 Million
Q4 2013 Feb 07, 2014	SELL	N/A	-25,153 Reduced 5.58%	425,461 $17.1 Million
Q3 2013 Nov 08, 2013	BUY	N/A	5,355 Added 1.2%	450,614 $17 Million
Q2 2013 Aug 13, 2013	BUY	N/A	445,259	445,259 $17.5 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.